Invention Grant
- Patent Title: Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
-
Application No.: US13503625Application Date: 2010-10-29
-
Publication No.: US09855212B2Publication Date: 2018-01-02
- Inventor: Colette Cozean , Rodney Benjamin , Anthony Keller , Jeff Varelman
- Applicant: Colette Cozean , Rodney Benjamin , Anthony Keller , Jeff Varelman
- Applicant Address: US CA Lake Forest
- Assignee: Abela Pharmaceuticals, Inc.
- Current Assignee: Abela Pharmaceuticals, Inc.
- Current Assignee Address: US CA Lake Forest
- Agency: Sheppard, Mullin, Richter & Hampton LLP
- International Application: PCT/US2010/054871 WO 20101029
- International Announcement: WO2011/053875 WO 20110505
- Main IPC: A61K31/4409
- IPC: A61K31/4409 ; A61K31/133 ; A61K31/496 ; A61P31/06 ; A61K9/00 ; A61K31/10 ; A61K45/06 ; A61K31/17 ; A61K31/4965 ; A61K31/7036
Abstract:
Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
Public/Granted literature
Information query
IPC分类:
